Work Package 9: “omics NOE” for cancer
This WP will focus on the development of a NoE fostering the integration of omic technologies into the EU healthcare systems (HCSs) to ameliorate prevention, diagnosis and treatment of cancer. Indeed, cancer is to be considered as a disease that should be prevented, early/timely diagnosed and treated appropriately within a continuum (the PDT cycle).
The specific objectives will include the definition of:
- the scope of the omics technologies “as is” and “to be”
- the scope of NoE on omics resources “as is” and “to be”
- the tasks and roles of an NoE ‘omics’
- the integration of omics NoE in the European/global omics ecosystem
- the omics NoE governance structure
- its sustainability
- its indicators of efficacy and its cost/efficacy constraintsits relationship with MSs, other EU and national networks, patients and citizen
Lead Beneficiary: SCIENSANO